Decision to list peritoneal dialysis equipment and consumables by Baxter Healthcare Limited

Hospital devices

Decision

We are pleased to announce the approval of a listing agreement for the supply of medical devices to DHBs.

What we’re doing

We are pleased to announce the approval of a listing agreement with Baxter Healthcare Limited (“Baxter”) for the supply of peritoneal dialysis equipment and consumables to DHBs.

In summary this will result in:

  • Baxter’s products being listed in Part III of Section H of the Pharmaceutical Schedule from 1 April 2021 under a national agreement that all DHBs may purchase under (the “Agreement”); and
  • DHBs being able to continue to purchase other suppliers’ brands of peritoneal dialysis equipment and consumables.

Who we think will be most interested

  • DHB staff
    • Procurement managers
    • Peritoneal dialysis staff
  • Peritoneal dialysis patients
  • Suppliers and wholesalers

Details about this decision

In coordination with PHARMAC, NZ Health Partnerships (“NZHP”) has previously released Requests for Proposals (“RFPs”) for ranges of medical devices which PHARMAC may list on the Pharmaceutical Schedule. Baxter and NZHP entered an agreement in 2018 to supply peritoneal dialysis equipment and consumables.

In September 2020, PHARMAC released an ROI as an opportunity for suppliers to have their peritoneal dialysis equipment and consumables considered for listing on the Pharmaceutical Schedule.

As Baxter had an agreement in place with NZHP for peritoneal dialysis equipment and consumables, the Agreement between Baxter and PHARMAC was based on that agreement. As there were no material changes made to the terms and conditions that are currently in place, PHARMAC decided that consultation on the provisional Agreement was not required and PHARMAC has decided to list peritoneal dialysis equipment and consumables in Part III of Section H of the Pharmaceutical Schedule from 1 April 2021.

The list of products will be available on PHARMAC's website from 1 April 2021, in both PDF and Excel formats.

DHBs can continue to choose which peritoneal dialysis equipment and consumables they purchase, including from other suppliers. DHBs that purchase peritoneal dialysis equipment and consumables from Baxter must do so under the terms and conditions, including pricing, in the PHARMAC Agreement from 1 April 2021.

The Agreement includes terms and conditions for training and education to be provided by Baxter on the appropriate use of its peritoneal dialysis equipment and consumables, which is to be provided at times and in formats as agreed with individual DHBs.

If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.